
Sign up to save your podcasts
Or


This program covers 2022 publications in the field of pulmonary hypertension with emphasis on important findings including treatment, risk assessment, diagnosis, and patient management. Content includes practice-impacting abstracts from the 2021 ATS and CHEST annual meeting. The impact of these important new findings are considered in light of current treatment and diagnostic doctrine.
By ReachMD4.3
33 ratings
This program covers 2022 publications in the field of pulmonary hypertension with emphasis on important findings including treatment, risk assessment, diagnosis, and patient management. Content includes practice-impacting abstracts from the 2021 ATS and CHEST annual meeting. The impact of these important new findings are considered in light of current treatment and diagnostic doctrine.